Your browser doesn't support javascript.
loading
How often are nonenhancing supratentorial gliomas malignant? A population study.
Scott, J N; Brasher, P M A; Sevick, R J; Rewcastle, N B; Forsyth, P A.
Afiliación
  • Scott JN; Department of Diagnostic Imaging, University of Calgary, Alberta, Canada.
Neurology ; 59(6): 947-9, 2002 Sep 24.
Article en En | MEDLINE | ID: mdl-12297589
The presence of contrast enhancement in a brain tumor is often regarded as a sign of malignancy. The authors identified 314 patients with malignant and low-grade supratentorial glial neoplasms in an unselected population, 58 of which lacked contrast enhancement on preoperative neuroimaging. Nonenhancing gliomas were malignant in approximately one third of cases, especially in older patients. Histologic confirmation of the diagnosis is therefore important in all patients suspected of harboring a primary glial neoplasm.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Supratentoriales / Glioma Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: America do norte Idioma: En Revista: Neurology Año: 2002 Tipo del documento: Article País de afiliación: Canadá
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Supratentoriales / Glioma Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: America do norte Idioma: En Revista: Neurology Año: 2002 Tipo del documento: Article País de afiliación: Canadá